Sahlgrenska University Hospital | Gothia Forum - Clinical Trial Center
Status
Conditions
Treatments
About
The aim of INS.CORT trial is, by studying glycemic variability in a well-defined patient group with both insulin & hydrocortisone (patients with concomitant insulin-treated diabetes & Addison's disease) and collecting information about the administration -time point and doses- of insulin, hydrocortisone and food intake with the help of new technology to improve the treatment in all patients treated with both insulin & glucocorticoids.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Men and women at age 18 to 70 years, with BMI 18-32 kg/m2 and well-defined both insulin-treated diabetes & Addison's disease for >12 months each, on insulin treatment and stable hydrocortisone replacement with once-daily dual-release hydrocortisone (20-30 mg/day) for >3 months.
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
16 participants in 2 patient groups
Loading...
Central trial contact
Dimitrios Chantzichristos, MD PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal